Comparison of phenotypic methods for the detection of penicillinase in Staphylococcus aureus and proposal of a practical diagnostic approach by Hombach, Michael et al.








Comparison of phenotypic methods for the detection of penicillinase in
Staphylococcus aureus and proposal of a practical diagnostic approach
Hombach, Michael ; Weissert, Christoph ; Senn, Maria Magdalena ; Zbinden, Reinhard
Abstract: Objectives Disc diffusion is a cost-efficient, low-complexity, reliable method for detection of blaZ
-mediated benzylpenicillin resistance in Staphylococcus aureus if the zone edge is inspected. EUCAST
breakpoints cannot fully separate ฀-lactamase-positive from ฀-lactamase-negative strains, and EUCAST
recommends the zone edge test. Literature on nitrocefin-based testing and the zone edge test is scarce with
wide variations in reported assay performance. Methods This study compared two different nitrocefin-
based commercial and in-house tests and the EUCAST-based zone edge test for penicillinase detection
in S. aureus applying a PCR-based gold standard. Results In total, 215 non-duplicate clinical S. aureus
isolates were included in the study, of which 127 (59.1%) did not harbour a blaZ gene, whereas 88
(40.9%) were blaZ positive. This study showed that for blaZ detection the zone edge test is more
sensitive (96.6%) than nitrocefin tests independent of using nitrocefin discs (87.5% sensitivity) or solution
(89.8% sensitivity), and that the significant inter-person variations of the zone edge test are probably
related to the training level of the individual investigators (individual sensitivity ranging from 68.2%
to 96.6%, specificity ranging from 89.8% to 100%). Conclusions In addition to continued and strict
training of investigators, we propose mandatory checking of benzylpenicillin zone edges, particularly in
an investigation zone from 26 to 30 mm, which can result in improved specificity/positive predictive value
of the zone edge test (from 98.4% to 100%) but retains the high sensitivity/negative predictive value of
the method.
DOI: https://doi.org/10.1093/jac/dkw521





Hombach, Michael; Weissert, Christoph; Senn, Maria Magdalena; Zbinden, Reinhard (2017). Comparison
of phenotypic methods for the detection of penicillinase in Staphylococcus aureus and proposal of a
practical diagnostic approach. Journal of Antimicrobial Chemotherapy, 72(4):1089-1093.
DOI: https://doi.org/10.1093/jac/dkw521
Comparison of phenotypic methods for the detection of penicillinase
in Staphylococcus aureus and proposal of a practical diagnostic
approach
Michael Hombach1*, Christoph Weissert2, Maria Magdalena Senn1 and Reinhard Zbinden1
1Institut für Medizinische Mikrobiologie, Universit€at Zürich, Zürich 8006, Schweiz; 2Zentrum für Labormedizin, 9001 St Gallen, Schweiz
*Corresponding author. Institut für Medizinische Mikrobiologie, Universit€at Zürich, Gloriastr. 30/32, Zürich 8006, Schweiz.
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Objectives: Disc diffusion is a cost-efficient, low-complexity, reliable method for detection of blaZ-mediated
benzylpenicillin resistance in Staphylococcus aureus if the zone edge is inspected. EUCAST breakpoints cannot
fully separate b-lactamase-positive from b-lactamase-negative strains, and EUCAST recommends the zone
edge test. Literature on nitrocefin-based testing and the zone edge test is scarce with wide variations in reported
assay performance.
Methods: This study compared two different nitrocefin-based commercial and in-house tests and the
EUCAST-based zone edge test for penicillinase detection in S. aureus applying a PCR-based gold standard.
Results: In total, 215 non-duplicate clinical S. aureus isolates were included in the study, of which 127 (59.1%)
did not harbour a blaZ gene, whereas 88 (40.9%) were blaZ positive. This study showed that for blaZ detection
the zone edge test is more sensitive (96.6%) than nitrocefin tests independent of using nitrocefin discs (87.5%
sensitivity) or solution (89.8% sensitivity), and that the significant inter-person variations of the zone edge test
are probably related to the training level of the individual investigators (individual sensitivity ranging from 68.2%
to 96.6%, specificity ranging from89.8% to 100%).
Conclusions: In addition to continued and strict training of investigators, we propose mandatory checking of
benzylpenicillin zone edges, particularly in an investigation zone from 26 to 30mm,which can result in improved
specificity/positive predictive value of the zone edge test (from 98.4% to 100%) but retains the high sensitivity/
negative predictive value of themethod.
Introduction
Penicillin-resistant Staphylococcus aureuswere described soon after
benzylpenicillin had entered clinical practice.1–3 In Switzerland, the
prevalence of benzylpenicillin-resistant S. aureus (non-MRSA) has
been reported to have remained stable at about 80% for the last 5
years.4 Despite this high number of resistant isolates, benzylpenicil-
lin nevertheless remains of clinical importance due to its few side ef-
fects, strong bactericidal effect, wide dosing range, targeted
spectrum of activity and low therapeutic costs. In the University
Hospital of Zurich that is served by the Institute of Medical
Microbiology, University of Zurich, benzylpenicillin is, therefore, regu-
larly used, if the organism tests as susceptible, e.g. for S. aureus.
Disc diffusion is considered more reliable than MIC testing for
the detection of blaZ-mediated benzylpenicillin resistance.5
However, EUCAST also states that the benzylpenicillin clinical zone
diameter breakpoint of 26mm (which equals the epidemiological
cut-off, i.e. the ECOFF) will not completely separate b-lactamase
producers (non-WT) from b-lactamase non-producers (WT), i.e.
both populations overlap and the ECOFF is not discriminatory.5,6
EUCAST has, therefore, been recommending the zone edge test in
addition to clinical breakpoints (CBPs) from its first guideline ver-
sions on, and, in addition, explicitly discourages the use of chromo-
genic cephalosporin-based b-lactamase tests in its most recent
guidelines (version 6.0, similar to current CLSI 2016 guidelines)
starting with EUCAST breakpoint tables version 2.0.5,7–9 The avail-
able literature on nitrocefin-based penicillinase testing and the
zone edge test is, however, scarce with wide variations in the re-
ported assay performance parameters. Although more recent
studies triggered the latest EUCAST recommendations, the original
zone edge criterion was proposed as long ago as 1981.10 CLSI
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guidelines contain recommendations for inspection of the penicil-
lin zone edge that are similar to EUCAST even though disc potency
and zonediameter CBP differ.7
The aims of our study were: (i) to compare different chromo-
genic nitrocefin-based commercially available and in-house tests
for the detection of penicillinase activity in S. aureus; (ii) to deter-
mine the extent of investigator-dependence and the influence of
methodological variables on the zone edge test to elucidate the
wide variations in reported sensitivity; and (iii) to develop a prac-
tical approach to optimize the application of the zone edge test in
a routine clinical laboratory.
Materials and methods
Bacterial isolates
In total, 215 non-duplicate clinical S. aureus isolates recovered in our clinical
laboratory from2010 until 2015were included in the study (Table 1). For all
isolates MRSA was excluded by cefoxitin susceptibility according to the cur-
rent EUCAST/CLSI breakpoint (22mm).5,7 Isolates displaying benzylpeni-
cillin zone diameters ranging from 15 to 40mm were selected as a
representative sample (Figure 1). Isolates with benzylpenicillin zone diam-
eters <15mm were not included as production of a penicillinase can be
assumed with high probability. All isolates were genetically characterized
for the presence of blaZ penicillinases (types A, B, C and D, representing the
worldwide genetic variation). 127/215 isolates (59.1%) did not harbour a
blaZ gene, whereas 88/215 isolates (40.9%) were blaZ positive. All isolates
were subcultured twice on Columbia sheep blood agar (bioMérieux, Marcy-
l’Etoile, France) prior to performing the assays.
Genetic detection of blaZ genes
Total DNA was extracted from bacterial colonies after growth on sheep
blood agar using the InstaGene Matrix (Bio-Rad, Reinach, Switzerland).
Genetic detection of blaZ genes was done by two classical endpoint PCRs
for all 215 isolates and primers to cover all blaZ subtypes (A, B, C and D, rep-
resenting the worldwide genetic variation): one PCR followed an in-house
protocol and covered subtypes A, C and D; and a second PCR detecting sub-
type B was done as described elsewhere.11 The in-house blaZ PCR was
performed using 5lL of 10 FastStart PCR buffer with 20mMMgCl2 (Roche
Diagnostics, Rotkreuz, Switzerland), 5lL of dNTP-Mix (2mM, in-house,
3 dUTP), 1lL of primers blaZ-fwd (50-CAACGTCTAAAAGAACTAGG-30) and
blaZ-rev (50-CCTTCATTACACTCTTGG-30) amplifying a 418bp fragment (nu-
cleotide position 420–838), 0.25lL of FastStart Taq DNA polymerase (5U/
lL, Roche), 5lL of DNA extract and 32.75lL of molecular grade water
(Roche) in a total reaction volume of 50lL. The PCR protocol comprised an
initial denaturation at 94 C for 5min followed by 35 cycles of 94 C for 45s,
48 C for 45s and 72 C for 45s, and a final extension at 72 C for 10min.
The PCR products were separated in a 1.1% agarose gel (Invitrogen AG,
Basel, Switzerland) in 0.5 Tris-borate-EDTA buffer at 120 V for 50min
and stained with GelRed (Chemie Brunschwig, Basel, Switzerland).
A 100–1500bp ladder (XIV, Roche)was used todetermine the size of ampli-
cons. gyrB amplification was used as an amplification control as described
by other authors.12 In each PCR run control strains were included: S. aureus
ATCC 29213 served as a positive control for blaZ, while S. aureus ATCC
25923was usedas a blaZ-negative control strain.
Susceptibility testing
Disc diffusion susceptibility testing was done according to EUCAST rec-
ommendations.5 Antibiotic discs were obtained from i2a, Montpellier,
France, and Mueller–Hinton II agar was obtained from Becton Dickinson,
Franklin Lakes, NJ, USA. Inhibition zone edges of benzylpenicillin 1U discs
were read by nine investigators with different levels of training and ex-
perience in the inspection of benzylpenicillin zone edges, ranging from a
comprehensive basic introduction that is given to all new readers in our
laboratory using the EUCAST reading guide including relevant images (in-
vestigator 8 representing an entry level), or long-standing experience but
no current daily routine use (investigators 1, 2 and 4) up to highly experi-
enced and daily routine-trained investigators (investigators 3, 5–7 and
9).13 Investigators were either technicians with different levels of profes-
sional experience (investigators 5, 6 and 7 had laboratory practice of20
years and investigators 1 and 9 had laboratory practice of 5–10 years), or
represented academic medical microbiologists (investigators 3 and 4
had laboratory practice of20 years, investigator 2 had laboratory prac-
tice of 12 years and investigator 8 had diagnostic laboratory practice of 4
years). Investigators were asked to read in their normal way and zone
reading followed EUCAST recommendations, which are based on the ini-
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Figure 1. Distribution of benzylpenicillin 1U disc zone diameters for 215 S. aureus strains studied and genotype as determined by blaZ PCR (black
bars, blaZ-positive strains; grey bars, blaZ-negative strains).
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inspected using transmitted light in front of a dark background, i.e. angu-
lar transmitted illumination by a lamp in front of a black laminated
board; investigators 2, 4 and 8 used the naked eye in a distance of about
30 cm as recommended by EUCAST, whereas investigators 1, 3, 5–7 and
9 used a magnifying glass (currently discouraged by EUCAST).13 Zone
edges were classified as sharp if they were well defined and—in some in-
stances—fully developed colonies were visible within the inhibition zone
close to the zone edge. Zone edges were defined as fuzzy if they were
not clearly delimited, showing gradual tapering of growth.
Nitrocefin disc test
Nitrocefin discs (BBLTM CefinaseTM Paper Disks) were purchased from
Becton Dickinson, Franklin Lakes, NJ, USA and used according to the recom-
mendations of the manufacturer [package insert 8800801JAA(02),
2015-04]. Briefly, discsweremoistenedwith one drop of purifiedwater and
colony material picked from the cefoxitin inhibition zone edge on Mueller–
Hinton II agar to foster blaZ expression was smeared onto the discs using a
sterilized loop. Discs were checked for colour change after 60min. Colour
change from light yellow to orange/red was rated as a positive result; no
colour change was rated as a negative result. If it was unclear whether a
colour change had happened, the test was repeated three times, and if still
unclear the result was recorded as inconclusive and considered positive for
the calculation as in clinical practice it seems reasonable to report doubtful
penicillin susceptibility tests as resistant. S. aureus ATCC 29213 served as a
positive control, while S. aureus ATCC 25923was used as a negative control
strain for each run.
Nitrocefin solution test
Nitrocefin powder was purchased from Becton Dickinson, Franklin Lakes, NJ,
USA (for research use only), dissolved in purified water to a concentration of
0.5mg/mL, and aliquotted in sterile plastic tubes (100lL, i.e. 50lg/tube) and
storedat –20 C. Aliquotswere thawedandadjusted to roomtemperature im-
mediately before starting the tests. One loop of colony material picked from
the cefoxitin inhibition zone edge on Mueller–Hinton II agar to foster blaZ
expressionwas resuspended per nitrocefin tube, and tubeswere incubated at
37 C for 60min and subsequently checked for colour changes. Colour
changes from light yellow to orange/redwere ratedas apositive result; no col-
our change was rated as a negative result. If it was unclear whether a colour
change had happened, the test was repeated three times, and if still unclear
the resultwas recordedas inconclusiveandconsideredpositive for thecalcula-
tion. S. aureus ATCC 29213 served as a positive control, while S. aureus ATCC
25923wasusedasanegative control strain for each run.
Software
All calculations were done using Microsoft Excel 2010 software (Microsoft
Corporation, Redmond,WA, USA).
Results
Benzylpenicillin zone diameters and detection of blaZ
Of the 136 S. aureus isolates displaying benzylpenicillin zone
diameters 26mm (i.e. EUCAST ECOFF and CBP), 127 (93.4%)
were blaZ negative, whereas blaZ was detected in 9 isolates
(6.6%; Figure 1). All 79 isolates with benzylpenicillin zone diam-
eters <26mmwere found to be blaZ positive. The sensitivity and
specificity, positive predictive value (PPV) and negative predictive
value (NPV) of the EUCAST ECOFF/CBP for the detection of the
blaZ-positive non-WT were thus 89.8%, 100%, 100% and 93.4%,
respectively (Table 1). Two isolates with a benzylpenicillin zone
diameter 26mm were found to be blaZ PCR positive (repeated
three times from independent colonies and independent DNA ex-
tractions), but negative in the nitrocefin assays and considered to
display a fuzzy zone edge by all nine investigators. To resolve
these discrepancies, we conducted a cloverleaf test using S. aur-
eus ATCC 25923 as the indicator strain as reported by other
authors.14 Both strains yielded a clearly positive result in the

















CBP only 79 0 127 9 215 89.8 100 100 93.4
Nitrocefin discd 77 0 127 11 215 87.5 100 100 92.0
Nitrocefin solutiond 79 0 127 9 215 89.8 100 100 93.4
Zone edge/
investigators
1 Y þþ þþ 85 2 125 3 215 96.6 98.4 97.7 97.7
2 N þþ þ 85 13 114 3 215 96.6 89.8 86.7 97.4
3 Y þþþ þþ 85 0 127 3 215 96.6 100 100 97.7
4 N þþþ þ 84 13 114 4 215 95.5 89.8 86.6 96.6
5 Y þþþ þþ 85 0 127 3 215 96.6 100 100 97.7
6 Y þþþ þþ 85 0 127 3 215 96.6 100 100 97.7
7 Y þþþ þþþ 85 1 126 3 215 96.6 99.2 98.8 97.7
8 N þ þ 60 2 125 28 215 68.2 98.4 96.8 81.7
9 Y þþ þþ 84 1 126 4 215 95.5 99.2 98.8 96.9
aPCR results were used as the gold standard; TP, true-positive; FP, false-positive; TN, true-negative; FN, false-negative.
bLevel of overall experience:þ,<5 years;þþ, 5–15 years;þþþ,>15 years.
cLevel of daily practice:þ, occasional zone reading;þþ, regular but not daily zone reading;þþþ, daily zone reading.
dInconclusive results were rated positive.
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cloverleaf test and were therefore considered true-positive for
the presence of blaZ.
Nitrocefin disc test
The sensitivity of the nitrocefin disc was 87.5% if the four inconclu-
sive/borderline results were considered positive, whereas specifi-
city was 100% (Table 1). The resulting NPV for the penicillinase
detectionwas 92%.
Nitrocefin solution test
The sensitivity of the nitrocefin solution test was 89.8% if the four
inconclusive/borderline results were considered positive, whereas
specificity was 100% (Table 1). The resulting NPV for the penicillin-
ase detectionwas 93.4%.
Zone edge test
Although themedian sensitivity and specificity, PPV and NPV of the
zone edge test for penicillinase detection were high, ranging up to
96.6%, 100%, 100% and 97.7%, significant inter-investigator dif-
ferences were observed (Table 1): the sensitivity of the zone edge
test ranged from 68.2% for investigator 8 to 96.6% for investiga-
tors 1–3 and5–7. Specificity varied between 100% for investigators
3, 5 and 6 and 89.8% for investigators 2 and 4. The 1-fold standard
deviation of sensitivity and specificity for all nine investigators was,
thus, 9.4% and 4.3%, respectively. While investigators with a com-
parably high level of overall experience yielded high sensitivities of
95.5%–96.6%, the less-experienced investigator 8 had a sensitivity
of 68.2%. However, even for experienced investigators specificities
variedwith their level of current daily practice, ranging from 89.8%
(investigator 4: overall laboratory experience of >20 years, occa-
sional zone reading, nomagnifying glasses used), to 98.4% (inves-
tigator 1: overall laboratory experience of 10 years, regular but not
daily zone reading, magnifying glasses used), to 99.2% (investiga-
tor 7: overall laboratory experience of 20 years, daily zone reading,
magnifying glasses used), up to 100% (investigators 3, 5 and 6:
overall laboratory experience each of 20 years, regular but not
daily zone reading, magnifying glasses used; Table 1). Thus, the
best sensitivities and specificities were yielded by experienced in-
vestigators in daily practice and usingmagnifying glasses.
Discussion
The benzylpenicillin ECOFF and the equal EUCAST CBP of 26mmdo
not reliably exclude the presence of blaZ (see Figure 1 and Table 1).
The NPV of the EUCAST CBP of benzylpenicillin, i.e. the correct as-
signment of an isolate to the blaZ-negative, benzylpenicillin-
susceptibleWT,was 93.4% in this study, leaving a significant risk of
therapeutic failure. Thus, EUCAST recommends using the zone
edge test as an additional criterion.5,7 The use of nitrocefin-based
assays for the confirmation of penicillin susceptibility is explicitly
discouraged. EUCAST recommendations are based on a limited
number of studies investigating the performance of nitrocefin-
based assays for blaZ detection, which show low sensitivity of
these tests ranging from 35.7% to 63%.14–16 Our results confirm
other reports of nitrocefin assays displaying lower sensitivity than
the zone edge test, although the sensitivity of both the disc- and
the solution-based nitrocefin test were higher in this study as
compared with others (87.5%–89.8%; Table 1). These differences
in sensitivitymay be explained by different study populations or by
the picking of colony material from the zone edge of the cefoxitin
inhibition zone in our study, fostering blaZ expression and subse-
quent enhancement of nitrocefin cleavage.17 The use of nitrocefin
solution instead of discs did not significantly increase sensitivity
(increase of 2.3%, Table 1). The additional working time for prepar-
ation of the nitrocefin solution tubes and the higher hands-on time
in performing the assay can probably not be justified by the limited
performance increase.
The zone edge test is proposed to display the best performance;
however, reported sensitivities are highly variable, ranging from
65.5% to 100%.14–16 This wide variation in reported performance
may be due to the assessment of the zone edge depending signifi-
cantly on the investigator carrying out the inspection (see Table 1).
Our results clearly show that the zone edge test has the potential
to be performedwith very high sensitivity and specificity: to achieve
acceptable sensitivity it is, however, essential to continuously train
readers using this test in addition to providing a comprehensive
introduction. In addition, the EUCAST recommendation of not using
magnifying glassesmayneed to be revisedas the trained investiga-
tors in this study used magnifying glasses (Table 1) and achieved
excellent results.13 Furthermore, it seems of critical importance to
follow EUCAST recommendations to ensure adequate reading, i.e.
examining the zone edges using transmitted light as stated in the
EUCAST disc diffusion manual.18 The EUCAST manual states that
plates should be ‘held up to light’. In addition, the use of a generally
dark background in contrast to angular transmitted light was con-
sidered helpful by the investigators in this study.
To increase specificity and to better standardize the zone edge
test, it would be of advantage even for experienced investigators to
limit zone edge testing to that particular diameter range of benzyl-
penicillin inwhich the blaZ-positive population and the S. aureusWT
population overlap (investigation zone). In our study this was the
case for a diameter range of 26–30mm (Figure 1). The uppermost
zone diameter value of the non-WT (30mm), which has been pro-
posed as resistant population cut-off (RCOFF), serves as the cut-off
for additional testing, i.e. zone edge.19 If this rule is followed, a sim-
ple and practical flow chart results (Figure 2), which classifies con-
firmed blaZ producers,WT and a borderline population according to
the penicillin zone diameter. If this algorithm had been applied, the
specificity of individual investigators would have been increased
from 89.8% to 98.4% and 99.2% (investigators 2 and 4, respec-
tively, who had less daily practice), or from 98.4%, 98.4% and
99.2% to 100% (investigators 1, 8 and 9, respectively, with more
daily routine practice). Importantly, the sensitivity remained gener-
ally unchangedwith the application of the investigation zone.
Limitations of this study are the restriction to one centre, one
regional population of S. aureus strains investigated, and the use of
media and discs from single manufacturers. A multi-laboratory,
geographically diverse study is needed to confirm these regional
findings. Furthermore, our results are primarily applicable only to
the EUCAST disc diffusionmethod as CLSI uses a different disc load
(10U) versus 1U (EUCAST) and, consequently, uses a different
breakpoint. Furthermore, the number of isolateswith a benzylpeni-
cillin zone diameter26mmand a fuzzy zone edge (nine isolates,
i.e. 6.6%)was comparably low.
In summary, there are five conclusions that can be drawn from
this study: (i) our data confirm the EUCAST ECOFF and CBP as well
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as the lack of sensitivity and specificity of these cut-offs, which ne-
cessitate an additional test for penicillinase detection; (ii) the zone
edge test is more sensitive than nitrocefin tests irrespective of
whether nitrocefin disc or solution is used—therefore in line with
EUCAST recommendations the nitrocefin tests should not be used;
(iii) the zone edge test shows significant investigator dependence
as demonstrated by varying sensitivity and specificity; (iv) thor-
ough training and continued practice is important to achieve an
acceptable performance in the zone edge test and magnifying
glassesmay improve investigator performance; and (v) an investi-
gation zone from26 to 30mmand the EUCAST benzylpenicillin 1U
disc could improve the specificity/PPV of the zone edge test whilst
retaining its high sensitivity/NPV.
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Figure 2. Proposed diagnostic flow chart for benzylpenicillin 1U EUCAST
testing and reporting in S. aureus.
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